🔎 Trials Near Me

Akèy › Maladi Entestinal Anflamatwa › Missouri

Etid klinik pou Maladi Entestinal Anflamatwa nan Missouri

7 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan Missouri.

Vil nan Missouri

Tèks ofisyèl etid la (Anglè)

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-006, St Louis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • University Health Truman Medical Center, Kansas City
  • ak 6 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

Study of DISC-0974-201 in Participants With IBD and Anemia

  • KAD Clinical Research, St Louis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07368972

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • SSM Health DePaul Hospital- St. Louis, Bridgeton
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT06226883

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 3
Laj 2 a 19 · Tout sèks · Mizajou Sep 22, 2026 · NCT04844606

BOOM-IBD2 Pivotal Clinical Trial

  • Gateway GI Research (Objective Health), St Louis
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Aug 6, 2026 · NCT06571669

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Bridgeton
  • Mirador Therapeutics Selected Site, Kansas City
  • Mirador Therapeutics Selected Site, Liberty
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.